GRANULES vs WOCKPHARMA: Stock Comparison

Granules India Limited vs Wockhardt Ltd

Live data: 22 July 2026, 3:02 PM IST • Source: NSE and company filings

Wockhardt Ltd is the larger company by market capitalisation. Granules India Limited shows a lower P/E, a higher ROE and a higher dividend yield, while Wockhardt Ltd shows faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Granules India Limited and Wockhardt Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, GRANULES is more favourable on 10 of 13 scored metrics and WOCKPHARMA on 3These counts are context-free and are not an overall rating.

Key Differences

Market Cap
WOCKPHARMA is the larger company
₹30,362 Cr vs ₹21,049 Cr
P/E Ratio
GRANULES has a lower P/E
36.28x vs 144.46x
P/B Ratio
GRANULES has a lower P/B
4.24x vs 6.23x
EPS
GRANULES has higher earnings per share
₹24.44 vs ₹13.1
Dividend Yield
GRANULES has a higher dividend yield
0.2% vs 0%
Revenue Growth (TTM YoY)
WOCKPHARMA has faster revenue growth
26% vs 22.8%
EPS Growth (TTM YoY)
GRANULES has faster EPS growth
31.3% vs 0%
Qtr Sales Growth
WOCKPHARMA has stronger quarterly sales growth
29.9% vs 22.8%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricGRANULESWOCKPHARMA
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricGRANULESWOCKPHARMA
Live Price₹853.25₹1,865.9
Day Change-2.56%-1.6%
Volume14.44 L7.19 L
52-Week High₹910₹2,422.3
52-Week Low₹432.6₹1,086.7
Distance from 52W High-6.24%-22.97%

Valuation

MetricGRANULESWOCKPHARMA
Market Cap₹21,049 Cr₹30,362 Cr
P/E Ratio36.28x144.46x
P/B Ratio4.24x6.23x
EPS₹24.44₹13.1
Book Value₹205.21₹304
Dividend Yield0.2%0%

Growth

MetricGRANULESWOCKPHARMA
Revenue Growth (TTM YoY)22.8%26%
EPS Growth (TTM YoY)31.3%0%
Qtr Sales Growth22.8%29.9%
Qtr Profit Growth44.6%688%

Profitability & Leverage

MetricGRANULESWOCKPHARMA
ROE13.7%6.11%
ROCE15.5%7.55%
Net Margin11.15%3.3%
Operating Margin22.1%19.3%
Debt to Equity0.3x0.45x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricGRANULESWOCKPHARMA
Promoter Holding37.67%49.08%
FII Holding17.5% 2.19 pp7.09% 0.1 pp
DII Holding16.11% 0.9 pp10.96% 0.41 pp
Public Holding28.38% 1.28 pp32.83% 0.52 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Granules India Limited and Wockhardt Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.